Yield10 Bioscience to Present at the 24th Annual H.C. Wainwright Global Investment Conference
September 08 2022 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the
“Company”), an agricultural bioscience company, today announced
that President and CEO Oliver Peoples, Ph.D. will present a
corporate overview at the 24th Annual H.C. Wainwright Global
Investment Conference on September 13, 2022 at 2:00 pm ET. The
conference is being held on September 12 – 14, 2022 at the Lotte
New York Palace Hotel.
A live webcast of the presentation and a replay will be
available on the Investor Relations section of the Company’s
website at IR Events & Presentations | Yield10 Bioscience,
Inc.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
that is using its differentiated trait gene discovery platform, the
“Trait Factory”, to develop improved Camelina varieties to produce
proprietary seed products, and to discover high value genetic
traits for the agriculture and food industries. Our goals are to
efficiently establish a high value seed products business based on
developing superior varieties of Camelina for the production of
feedstock oils for renewable diesel, PHA bioplastics and omega-3
(DHA+EPA) oils, and to license our yield traits to major seed
companies for commercialization in major row crops, including corn,
soybean and canola. Yield10 is headquartered in Woburn, MA and has
an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please
visit www.yield10bio.com, or follow the Company
on Twitter, Facebook and LinkedIn.
(YTEN-G)
Contacts:
Yield10 Bioscience:Lynne H. Brum, (617) 682-4693,
LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024